Defence, Security, Energy, Utilities, Finance, Pharmaceuticals
Home > Pharmaceuticals > UK

Diabetes

1st October to 2nd October 2013, London, United Kingdom

Overview

Open/Close

The global diabetes market is projected to double from $32bn to $64bn over the next 15 years as a result of changing demographics and new therapies entering the clinic.


Now at epidemic levels, diabetes will affect eight percent of the world’s adult population by 2030. As the number of diabetics grows, so too will the need for new treatments to mitigate the effects of diabetes-related disorders and diseases. With this in mind, SMi is very proud to present our 11th conference focusing on Diabetes, Secondary Complications, Regulation and  Innovation. The conference will take place on the 1st and 2nd October 2013 and will provide a unique platform to engage with industry professionals, KOLs and esteemed academia in the field of diabetic and metabolic disease. With a spotlight on areas such as: combination therapy, diabetic retinopathy, stem cell and islet technology and EU and FDA guidelines, Diabetes 2013 promises to be a truly unmissable event!

Benefits of Attending

Open/Close

Featured Speakers

Open/Close

Who Should Attend

Open/Close